MedPath

Diets, Lipoproteins and Inflammation Markers

Not Applicable
Completed
Conditions
Diet, Healthy
Vegan Diet
Inflammatory Response
Cardiovascular Diseases
Metabolic Syndrome
Interventions
Behavioral: Vegan diet
Registration Number
NCT05423457
Lead Sponsor
Buddhist Tzu Chi General Hospital
Brief Summary

Systematic inflammation and lipid profiles are two major therapeutic targets for cardiovascular diseases. The effectiveness of vegan diet has been reported (doi: 10.3389/fnut.2022.807810).

Aim:

To compare the effectiveness of a nutritionally balanced vegan diet and a Myplate diet ((Taiwanese version) on systematic inflammation and lipoprotein subclass.

Design: Randomized crossover design

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria

Patients with dyslipidemia (at least one of the following)

  • TG ≥ 150 mg/dL
  • TC ≥ 200 mg/dL
  • LDL-c≥ 130 mg/dL,
  • HDL-c < 45 mg/dL for male or < 55 mg/dL for female or receiving statin treatment

Exclusion Criteria (fulfill one of the following condition):

  • chronic kidney disease
  • history of coronary artery disease
  • ischemic heart disease,
  • heart failure,
  • stroke,
  • cancer of any type
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Vegan dietVegan dietParticipants were provided with and instructed to eat these foods: * flaxseed meal, * walnuts, * pecans, * extra-virgin olive oil, * Brazil nuts * Taiwanese purple laver (also known as "hong-mao-tai" or Bangia atropurpurea, and was selected to test for its vitamin B12 bioavailability). Each Participant has three group sessions and three individual nutrition counseling with a dietitian.
MyPlate (Taiwanese version)Vegan dietEach Participant has three group sessions and three individual nutrition counseling with a dietitian.
Primary Outcome Measures
NameTimeMethod
lipoprotein particles size12 weeks

lipoprotein particles size (nm)

Traditional cadiometabolic risk factors 112 weeks

TG(mg/dL), LDL-C(mg/dL), HDL-C(mg/dL), Total cholesterol(mg/dL)

Novel inflammatory markers for cardiovascular disease and Lipoprotein particles concentration12 weeks

GlycA (umol/L), lipoprotein particles concentration(umol/L)

Lipoprotein particles concentration12 weeks

lipoprotein particles concentration (nmol/L)

Trimethylamine-N-oxide12 weeks

TMAO (uM). TMAO is a low molecular weight compound that belongs to the class of amine oxides

Traditional cadiometabolic risk factors 312 weeks

HOMA-IR index (Homeostasis Model Assessment-Insulin Resistance index)

Traditional cadiometabolic risk factors 212 weeks

HbA1c(%)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hualien Tzu Chi Hospital

🇨🇳

Hualien City, Taiwan

© Copyright 2025. All Rights Reserved by MedPath